1. Home
  2. WEX vs ALKS Comparison

WEX vs ALKS Comparison

Compare WEX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WEX

WEX Inc. common stock

N/A

Current Price

$181.09

Market Cap

6.5B

ML Signal

N/A

Logo Alkermes plc

ALKS

Alkermes plc

N/A

Current Price

$47.08

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEX
ALKS
Founded
1983
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.6B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
WEX
ALKS
Price
$181.09
$47.08
Analyst Decision
Buy
Buy
Analyst Count
15
20
Target Price
★ $202.09
$57.74
AVG Volume (30 Days)
602.1K
★ 1.7M
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.93
N/A
EPS
★ 9.20
N/A
Revenue
★ $2,660,800,000.00
$1,475,899,000.00
Revenue This Year
$11.90
$23.60
Revenue Next Year
$2.45
$5.49
P/E Ratio
$19.49
★ N/A
Revenue Growth
★ 1.24
N/A
52 Week Low
$125.29
$27.00
52 Week High
$203.99
$55.67

Technical Indicators

Market Signals
Indicator
WEX
ALKS
Relative Strength Index (RSI) 47.79 62.40
Support Level $148.03 $44.07
Resistance Level $189.61 $47.41
Average True Range (ATR) 7.00 1.75
MACD -0.58 0.28
Stochastic Oscillator 32.27 75.85

Price Performance

Historical Comparison
WEX
ALKS

About WEX WEX Inc. common stock

WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: